UKTN studies….

Beckley Psytech, the psychedelic medication firm, has raised £3m of Series A funding to develop a pipeline of psychedelic medication into licensed pharmaceutical medicines for treating psychiatric and neurological ailments.

Investors within the spherical embrace distinguished British businessmen Jim Mellon and Richard Reed, co-founder of Innocent Drinks.

The Beckley Psytech staff includes expertise from the psychedelic and pharmaceutical fields. Co-founded by Lady Amanda Feilding and CEO Cosmo Feilding Mellen, the chief staff additionally consists of Marc Wayne as Chairman of Board and Dr Steve Wooding, Chief Scientific Officer.

More at. https://www.uktech.news/guest-posts/funding/beckley-psytech-raises-3m-series-a-20200630

 

Wikipedia

https://en.wikipedia.org/wiki/Amanda_Feilding

Amanda Feilding, Countess of Wemyss and March, is an English drug policy reformer, lobbyist[1] and analysis coordinator. In 1998 she based the Foundation to Further Consciousness, later renamed to the Beckley Foundation,[2] a charitable trust which initiates, directs and helps neuroscientific and medical analysis into the results of psychoactive substances on the mind and cognition. She has additionally co-authored over 50 papers revealed in peer-reviewed journals, in accordance with the Foundation.[3] The central intention of her analysis is to analyze new avenues of remedy for such psychological diseases as depressionanxiety and addiction, in addition to to discover strategies of enhancing well-being and creativity.

Feilding has been a proponent of exploiting the cognitive results of hashish for the reason that 1960s. She has experimented with trepanning, drilling a gap into the cranium to show the dura mater, a method utilized in some cultures to deal with psychological sickness, and regarded by some to supply a relaxing impact or a better state of consciousness.[2]

Feilding can be a proponent of using LSD to set off long-term enhancements in creativity.[4]

 

 

https://beckleyfoundation.org/amanda-feilding/

  Amanda Feilding has been known as the ‘hidden hand’ behind the renaissance of psychedelic science, and her contribution to international drug coverage reform has additionally been pivotal and extensively acknowledged. Amanda was first launched to LSD within the mid-1960s, on the peak of the primary wave of scientific analysis into psychedelics. Impressed by its capability to provoke mystical states of consciousness and heighten creativity, she rapidly recognised its transformative and therapeutic energy. Inspired by her experiences, she started finding out the mechanisms underlying the results of psychedelic substances and devoted herself to exploring methods of harnessing their potential to treatment illness and improve wellbeing. In 1996, Amanda arrange The Foundation to Further Consciousness, altering its title to the Beckley Foundation in 1998. She realised that the potential harms and advantages of hashish and psychedelics may solely be adequately assessed by creating a sound scientific understanding of their mechanisms of motion. Through the Foundation, she set about utilizing cutting-edge mind imaging applied sciences to look at the neurophysiological modifications underlying altered states of consciousness. Her long-held intention is to additional our understanding of consciousness and the way modifications in cerebral circulation and neuronal exercise underlie the results of varied psychoactive substances, in order that we are able to higher harness their potential to enhance the human situation. Having watched the event of the ‘War on Drugs’ with dismay, Amanda felt compelled to do no matter she may to attract consideration to its devastating and unintended penalties. Bringing collectively a community of main worldwide scientists, politicians and drug coverage analysts, she was among the many first to start making a scientific evidence-base to assist reform international drug insurance policies, so as to higher defend well being, scale back harms and financial prices, and uphold human rights. From 1998, she initiated and hosted a sequence of 11 worldwide seminars on the House of Lords, discussing key coverage points and drawing consideration to the ignored subjects of hashish and psychedelics. These seminars, and the studies arising from them, have been extremely influential in altering attitudes amongst thinkers and policy-makers worldwide. Through the Beckley Foundation’s Policy Programme, Amanda has commissioned and revealed over 40 books, studies, and coverage papers which have analysed the unfavourable penalties of the criminalisation of drug use, and laid out attainable alternate options which may defend public well being, diminish violence and governmental prices, and defend human rights. Over the years, her recommendation has been sought by presidents and governments, and in 2011, she wrote the influential public letter calling for drug coverage reform, which was signed by presidents, Nobel laureates, and different notables. Through her management of the Beckley Foundation’s Science Programme, Amanda has initiated a lot ground-breaking analysis and has co-authored over 50 scientific articles revealed in peer-reviewed journals. She collaborates with main scientists and establishments world wide to design and direct a variety of scientific analysis initiatives (together with medical trials) investigating the results of psychoactive substances on mind operate, subjective expertise, and medical signs, with a deal with hashish, the psychedelics (LSD, psilocybin, ayahuasca, DMT, 5-MEO-DMT) and MDMA. This pioneering analysis has not solely make clear the mechanisms of motion and therapeutic potential of those substances, but in addition on consciousness itself. This has led to a groundswell of curiosity in, and recognition of, the attainable advantages that cautious use of those extraordinary compounds can deliver. The analysis that Amanda has initiated has proven that psychedelics maintain nice promise in serving to people with diseases similar to treatment-resistant despair and dependancy. Furthermore, in her function as co-director of the Beckley/Imperial Research Programme, she helped generate the world’s first photographs of the mind on LSD, one among her long-standing ambitions. While her old flame is the science, Amanda continues to bridge the divide between science and drug coverage: her pioneering psychedelic analysis is offering the scientific proof to gasoline a good debate on drug coverage reform. Such reform will, in flip, enable for analysis on presently prohibited psychedelic substances to flourish, uninhibited by regulatory obstructions. Ultimately, the purpose of Amanda’s work is to make psychedelics and hashish into authorised medicines, in order that they are often legally prescribed at clinics for these in want.

 

Source link